Trinity Biotech (TRIB) EBT Margin (2009 - 2024)
Trinity Biotech's (TRIB) quarterly EBT Margin came in at 99.62% in Q4 2024, down 5863.0% year-on-year from 1.73% in Q1 2024, and down 214.87% quarter-over-quarter from 31.64% in Q3 2024.
Trinity Biotech (TRIB) EBT Margin (2009 - 2024) Analysis & Trends
Trinity Biotech has disclosed EBT Margin across 16 years of filings, most recently posting 99.62% for Q4 2024.
- EBT Margin for Q4 2024 came in at 99.62%, down 5863.0% year-over-year; the trailing twelve-month figure through Dec 2024 was 49.92% (up 1506.0% YoY), and the FY2025 annual result was 84.91%, down 3499.0% from the prior year.
- EBT Margin came in at 99.62% for Q4 2024 at Trinity Biotech, down from 31.64% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 32.29% in Q3 2020 to a low of 133.93% in Q2 2023.
- The 5-year median for EBT Margin is 36.32% (2024), against an average of 31.95%.
- Across the five-year window, EBT Margin sank 10110 bps in 2022 and jumped 9045 bps in 2024, its largest moves.
- Trinity Biotech's EBT Margin stood at 31.41% in 2020, then tumbled by 140 bps to 12.44% in 2021, then tumbled by 433 bps to 66.32% in 2022, then jumped by 38 bps to 41.0% in 2023, then slumped by 143 bps to 99.62% in 2024.
- The last three EBT Margin figures came in at 99.62% (Q4 2024), 31.64% (Q3 2024), and 43.48% (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.17% |
| 10 | Trinity Biotech | 23,520.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -99.62% |
| Sep 30, 2024 | -31.64% |
| Jun 30, 2024 | -43.48% |
| Mar 31, 2024 | -22.10% |
| Dec 31, 2023 | -41.00% |
| Sep 30, 2023 | -44.27% |
| Jun 30, 2023 | -133.93% |
| Mar 31, 2023 | -42.59% |
| Dec 31, 2022 | -66.32% |
| Sep 30, 2022 | -63.59% |
| Jun 30, 2022 | -65.84% |
| Mar 31, 2022 | -84.34% |
| Dec 31, 2021 | -12.44% |
| Sep 30, 2021 | 7.28% |
| Jun 30, 2021 | -0.50% |
| Mar 31, 2021 | 16.76% |
| Dec 31, 2020 | 31.41% |
| Sep 30, 2020 | 32.29% |
| Jun 30, 2020 | 10.96% |
| Mar 31, 2020 | 13.96% |